Biotech entity
pharma is the sole category represented across all 1 tracked stories. ibuprofen is most often covered alongside FDA, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. ibuprofen is most often covered alongside FDA, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. The 6 average consequence score is below the beat benchmark of 6.4 in the same window. We currently track 1 Biotech story that mention ibuprofen, all published on March 20, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering ibuprofen. Shared-story counts are live from our verified record — not editorial picks.
The FDA has announced a nationwide recall of approximately 90,000 bottles of children's ibuprofen due to potential safety risks and manufacturing concerns. This large-scale action highlights ongoing challenges in pediatric pharmaceutical quality control and could impact the availability of essential fever reducers.
ibuprofen is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
